Nichole Ammon and Simon Robins discuss consumer health information and the benefits of integrated behavioral health care. For more information about NEOMED Project ECHO programs, visit https://www.neomed.edu/projectecho/
The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
In this lecture, Dr. Dugan discusses the impact of nicotine on schizophrenia. By the end of this lecture, you will be able to: 1) describe the actions of nicotine on neurotransmitters, 2) list potential reasons for high use of nicotine products, specifically cigarettes in patients with schizophrenia, and 3) identify evidence of nicotine’s actions in patients with schizophrenia.
In this lecture, Dr. Dugan examines some of the potential therapeutic uses for amantadine, explains its mechanisms of action, and reviews potential risks. By the end of this lecture, you will be able to: 1) describe the mechanism of action of amantadine, 2) list the adverse effects associated with the use of amantadine, and 3) identify uses for amantadine in patients with mental health conditions.
In this lecture, Dr. Dugan discusses the tricyclic antidepressants including their mechanism of action, indications, dosing, monitoring, and common side effects. By the end of this lecture, you will be able to: 1) describe the pharmacology of the tricyclic antidepressants (TCA), 2) identify relevant pharmacokinetic differences between TCAs, and 3) evaluate the literature on TCAs for the treatment of depression.
